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Abstract 
With the increasing incidence of drug addiction among pregnant women, neonatal abstinence 
syndrome (NAS) has become a significant problem in the United States and has led to increased 
hospital costs, longer lengths of stay, and more serious health problems in neonates. This 
systematic review will explore the evidence about outcome differences for neonates with NAS 
that receive breastfeeding, rooming-in, and acupuncture in addition to pharmacological agents 
when compared to infants only receiving pharmacological agents. Twenty-one articles, retrieved 
from the databases PubMed and CINAHL and published between the years 2000-2017, were 
described in an integrated review, analyzed with critical appraisal, and synthesized for this 
systematic review. In general, researchers have found that breastfeeding, rooming-in, and 
acupuncture have positive effects of decreasing the need for pharmacological treatment, NAS 
symptoms, hospital costs, and length of hospital stay for infants with NAS when used in 
conjunction with pharmacologic agents.  
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Systematic Review: The Effects of Pharmacological and Nonpharmacological Measures in 
Neonates with Neonatal Abstinence Syndrome 
The use or abuse of illicit drugs by mothers during pregnancy puts infants at risk for 
neonatal abstinence syndrome. Illicit drugs cross the placentas and the fetuses can become 
dependent on these substances. At birth, neonates are no longer exposed to these substances and 
are then at risk for a wide range of withdrawal symptoms, known as neonatal abstinence 
syndrome (NAS). NAS is a condition which primarily affects the autonomic and central nervous 
systems, as well as the gastrointestinal system (Johnson, 2017). NAS causes many issues in 
neonates and clinical manifestations of NAS can vary in both severity and timing (McQueen & 
Murphy-Oikonen, 2016). Clinical manifestations of NAS typically develop within the first few 
days of life and can range in severity from mild tremors and irritability to fever, excessive weight 
loss, and seizures (McQueen & Murphy-Oikonen, 2016). 
Neonatal abstinence syndrome is a significant problem in the United States (Corr & 
Hollenbeak, 2017). Corr and Hollenbeak, (2017) revealed a 413% increase in the admissions of 
neonates suffering from NAS from 2003 to 2012. Along with the large increase in admissions of 
neonatal abstinence syndrome, the hospital lengths of stay also increased to the extent that 
neonates with NAS had lengths of stay that were about three times higher than those neonates 
not suffering from the syndrome. In 2003, NAS admissions cost the United States $60,643,042. 
In 2012, this financial load reached an astounding value of $315,665,913 (Corr & Hollenbeak, 
2017).  
Neonatal abstinence syndrome not only affects health care costs, number of admissions, 
and lengths of stay, but also has many detrimental effects on neonates (Corr & Hollenbeak, 
2017). Approximately 225,000 neonates are exposed to illicit substances each year (MacMullen, 
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Dulski, & Blobaum, 2014). Of the neonates exposed to drugs in utero, greater than 75% have 
major medical problems, compared with 27% of unexposed infants (MacMullen et al., 2014). 
Because infants suffering from NAS tend to have major medical problems, these infants require 
extensive nursing care consisting of a number of interventions. Common interventions used to 
treat infants suffering from NAS include pharmacological measures, such as methadone and 
buprenorphine, and nonpharmacological measures, such as rooming-in, acupuncture, low-
stimulation environment, and encouraging mothers to breastfeed neonates.  
This systematic review was guided by the following PICOT question: In neonates with 
neonatal abstinence syndrome, how do supplemental nonpharmacological measures, compared 
with treatment as usual (pharmacological measure alone), affect outcomes? The purpose of this 
systematic review is to describe and critically appraise the evidence about outcomes of 
supplemental breastfeeding, rooming-in, and acupuncture in neonates with NAS, when compared 
to neonates with NAS that received only pharmacological agents.  
Methods 
 A systematic review of the literature was conducted to answer the PICOT question.   The 
databases PubMed and CINAHL were used to collect 21 peer reviewed journal articles published 
between the year 2000 and 2017. Intervention types included pharmacological agents, 
breastfeeding, and supportive interventions, including acupuncture, rooming-in, and reducing 
stimulation in the environment. Key words were “breastfeeding,” “neonatal abstinence 
syndrome,” “pregnancy and drug dependence and breastfeeding,” “neonatal abstinence 
syndrome and medications,” “maternal methadone use and neonatal abstinence syndrome,” 
“neonatal withdrawal syndrome and treatments,” “methadone maintenance program and neonatal 
abstinence syndrome,” “neonatal abstinence syndrome and acupuncture,” “neonatal abstinence 
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syndrome and interventions,” and “neonatal abstinence syndrome and rooming-in.” MeSH, or 
Medical Subject Headings, is the National Library of Medicine’s controlled vocabulary thesaurus 
that is used to index articles for Pubmed. MeSH included “neonatal abstinence syndrome,” “drug 
therapy,” and “breastfeeding.”  Integrated review, analysis with critical appraisal, and synthesis 
of the reviewed articles were accomplished through the use of a matrix of evidence which 
included the article’s title, author, purpose statement, research question, clinical practice setting, 
sampling methods, sample size, research design, level of evidence, research findings, 
practice/research implications, and limitations of findings (Appendix A). 
Review of the Literature 
 Pharmacological interventions aimed at treating the symptoms of NAS have been studied 
extensively. Opioid maintenance programs using methadone and buprenorphine are critical to 
preventing NAS in order to improve the health of neonates (Kakko, Heilig, & Sarman, 2008). In 
addition to pharmacological management of NAS, researchers have examined the effect of many 
nonpharmacological methods on outcomes in neonates with NAS. For the purpose of this 
systematic review, the interventions include breastfeeding, rooming-in, and acupuncture. This 
systematic review of literature will provide an in-depth discussion of the studies that have 
evaluated these interventions on NAS-related outcomes. 
Pharmacological measures.  In order to compare the treatments and outcomes for babies 
with NAS, it is important to know the standard treatment provided today. Buprenorphine and 
Methadone are the two most common pharmacological measures to reduce the severity of NAS 
seen in babies born to opioid-dependant mothers (Kakko et al., 2008).  
Target action. Opioid-dependent mothers are given Buprenorphine or Methadone early 
in their pregnancy to reduce the effects of opioids on their unborn infants as part of an opioid 
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maintenance program (Kakko et al., 2008). Opioid maintenance programs are very important to 
the health of infants and the prevention of neonatal abstinence syndrome. Ebnar, Rohrmeister, 
Winklbaur, Baewert, Jagsch, Peternell, and Fischer (2007) demonstrated that infants born to 
mothers with drug addiction who were on an opioid maintenance program (N=53) showed 
comparable APGAR scores with infants born to non-opioid dependent mothers (N=53). The 
APGAR score is an assessment done at birth to determine if newborns are ready to live without 
additional medical assistance. APGAR assessment focuses on five important factors of neonate 
health: (1) baby’s appearance, (2) pulse, (3) muscle activity, (4) breathing and (5) 
responsiveness.  
 Buprenorphine and Methadone are two drugs that are used to help persons addicted to 
drugs avoid using illicit drugs. They target the same receptors that drugs, such as heroin, target, 
therefore making persons with addiction feel satisfied, but in a more controlled and regulated 
state to prevent the harmful side effect of withdrawal. Methadone is an opioid agonist, which 
means that the drug binds to the central μ receptors and reduces pain impulses. It is used in 
maintenance programs because it is easy to control and has a similar effect of illicit drugs but 
does not give the euphoria, in turn decreasing reward responses and likelihood of addiction. This 
drug is a schedule II, which means it is controlled and can potentially be very dangerous if 
abused.  On the other hand, Buprenorphine is a partial opioid agonist, which means that it is 
weaker and there is less chance of abuse. An opioid antagonist, such as Narcan, is an antidote for 
opioid agonists. Therefore, when Buprenorphine and Methadone are used in combination, the 
persons feel as if they are on an opioid, but it is, in essence, a safe opioid used to prevent them 
from abusing or overdosing. Buprenorphine is a schedule III, which means it has a lower risk of 
NEONATAL ABSTINENCE SYNDROME                                                                                7  
 
addiction than methadone, but still has potential to become dangerous (Kee, Hayes, & 
McCuistion, 2009).  
Research findings. Between Buprenorphine and Methadone, as used for opioid 
maintenance, Buprenorphine has been found to be more effective (Jones, Kaltenbach, Heil, 
Stine, Coyle, Arria, & Fischer, 2010; Kakko, et al., 2008). When mothers were given 
Buprenorphine early in pregnancies, neonates are less likely to  experience withdrawal, less 
Morphine is required for treatment, higher birth weights and full term pregnancies result, and 
hospital stays are shorter (Jones et al, 2010; Kakko et al, 2008). Ebnar et al. (2007) found that in 
cases where mothers were not compliant with treatment or infants were experiencing withdrawal 
symptoms, morphine, when given to the neonates, was the most effective treatment for neonatal 
abstinence syndrome.  
Several researchers have compared the effect of different opioid maintenance program 
dosing schedules on NAS-related outcomes in neonates. Findings demonstrate no differences in 
outcomes relative to program dosing schedules (Cleary, Reynolds, Eigan, O’connell, Fahey, 
Gallagher, & Murphy, 2013; Kuschel, Austerberry, Cornwell, Couch, & Rowley, 2004). 
Typically, some programs increase dosages of methadone in the later stages of pregnancy to 
reduce the likelihood of mothers going into withdrawal or drug relapse, and others decrease 
dosages in later stages to prevent neonates from going into neonatal abstinence syndrome. Cleary 
et al. (2013) categorized dosing patterns into three categories: (1) increasing Methadone dosages 
in later stages of pregnancies, (2) decreasing Methadone dosages in later stages of pregnancies, 
or (3) no change in Methadone dosing throughout pregnancies. The outcome of medically treated 
neonatal abstinence syndrome did not differ between groups (Cleary et al, 2013). However, 
according to Kuschel et al. (2004), Methadone-exposed infants who required treatment for 
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neonatal abstinence syndrome had lower amounts of methadone in their system than those who 
did not receive treatment. The results of these studies suggest that dosages can remain consistent 
throughout the opioid maintained pregnancies with little to no adverse effect on the neonate 
(Cleary et al., 2013).  
Summary.  When women are addicted to illicit drugs, such as heroin, and they find they 
are pregnant, they may be enrolled in opioid maintenance programs using either Buprenorphine 
or Methadone. Both of these medications target the same receptors targeted by drugs such as 
heroin, therefore decreasing the harmful side effect of withdrawal. When looking at these two 
drugs, Buprenorphine has been found to be the superior. This drug regime resulted in less infants 
going through withdrawal, less morphine required for treatment, higher birth weights due to 
infants going full term, and shorter hospital stays (Jones et al, 2010; Kakko et al, 2008). 
Although it is best to start on programs before conception, starting them as early as possible in 
the pregnancy is shown to yield better outcomes. If neonates are born and show severe signs of 
withdrawal, morphine has been shown to be the best drug for managing the symptoms (Ebnar et 
al, 2007).   
Breastfeeding. The effect of breastfeeding on NAS has been researched extensively in 
the literature. Seven studies in this systematic review tested the effects of breastfeeding on NAS 
(Dryden, Young, Hepburn, & Mactier, 2009; Isemann, Meinzen-Derr, & Akinbi, 2011; 
McQueen, Murphy-Oikonen, Gerlach K, & Montelpare, 2011; Mohamed, Abde-Latif, Pinner, 
Clews, Cooke, Lui, & Oei, 2006; O'Connor, Collett, Alto, & O'Brien, 2013; Pritham, Paul, & 
Hayes, 2012; Welle-Strand, Skurtveit, Jansson, Bakstad, Bjarko, & Ravndal, 2013). These 
researchers consistently showed that breastfeeding may reduce the incidence and duration of 
pharmacological treatment of neonates with NAS, reduce the length of hospitalization, and 
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reduce the severity of NAS. Description of studies in this integrated review are organized based 
on those three outcomes.  Samples of these seven studies included neonates suffering from NAS 
ranging from 28 to 450 neonates; samples in five of the seven studies were greater than 120 
neonates. Of the seven studies, the designs were retrospective cohort design, retrospective chart 
review, and prospective design. Studies were conducted at hospitals, ranging from rural to inner-
city settings in the United States, Canada, United Kingdom, and Australia. Limitations of these 
studies included small samples of buprenorphine-exposed infants, potential Finnegan 
instrumentation bias, non-randomized group assignments due ethical considerations, and 
retrospective data collection from available medical records, often resulting in incomplete data.  
Incidence and duration of pharmacological treatment.  As stated above, researchers 
have consistently found that breastfeeding reduces incidence and duration of pharmacological 
treatment in neonates exposed to methadone in utero (Dryden et al., 2009; Mohamed et al., 2006; 
Welle-Strand et al., 2013). Breastfeeding for greater than 72 hours was associated independently 
with a 50% reduced need for pharmacological treatment of NAS in methadone-exposed infants 
(Dryden et al., 2009). According to Welle-Strand et al. (2013), only 53% of the methadone-
exposed infants being breastfed required pharmacological treatment while 80% of the 
methadone-exposed infants not being breastfed required pharmacological treatment for NAS. 
Similarly, Mohamed et al.  (2006), found that 52.9% of the breastfed infants required 
pharmacological treatment for withdrawal while 79.0% of the formula-fed infants required 
pharmacological treatment for withdrawal. 
Breastfeeding has also been found to shorten length of pharmacological treatment of 
NAS in infants exposed to methadone (Isemann et al., 2011; Mohamed et al., 2006; Welle-Strand 
et al., 2013). According to Welle-Strand et al. (2013), a significantly shorter duration of 
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pharmacological treatment of NAS was found in methadone-exposed infants linked to lactation 
status. The duration of treatment for breastfed infants exposed to methadone was 31 days while 
the duration of treatment for methadone-exposed infants who were not breastfed was 48.9 days. 
Likewise, Isemann etal. (2011) discovered that maternal breast milk feedings decreased median 
duration of methadone therapy for NAS in both preterm and term infants. The median duration 
of methadone therapy for NAS in breastfed infants was less than ten days while the median 
duration of methadone therapy in formula-fed infants was greater than ten days. Lastly, 
Mohamed et al. (2006) found that overall NAS pharmacological treatment duration was almost 
20 days less in breastfed infants compared to formula-fed infants. The duration of 
pharmacological treatment for breastfed infants was 85.4 days while the duration of treatment for 
formula-fed infants was 108.2 days. 
Hospital stays.  Additionally, researchers have found that infants suffering from NAS 
who were breastfed had shorter hospital stays than formula-fed infants suffering from NAS 
(Isemann et al., 2011; Mohamed et al., 2006; Pritham et al., 2012). According to Isemann, 
Meinzen-Derr, and Akinbi (2011), maternal breast milk decreased hospital length of stay 
compared to formula-fed infants. The median length of hospital stay for breastfed infants 
suffering from NAS was 12.5 days while the median length of stay for formula-fed infants was 
18.5 days. Mohamed, Abde-Latif, Pinner, Clews, Cooke, Lui, and Oei (2006) found similar 
results with a shorter length of hospitalization among breastfed infants compared to formula-fed 
infants. In their study, the length of hospitalization in breastfed infants was 14.7 days compared 
to 19.1 days in formula-fed infants. 
 Severity of NAS.  Breastfeeding has also been found to reduce severity of NAS (Isemann 
et al., 2011; McQueen et al., 2011; Mohamed et al., 2006; O’Connor et al., 2013). The incidence 
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and severity of NAS is measured using the Finnegan objective scoring system. Finnegan scoring 
systems assess the severity of NAS by observing central nervous system, gastrointestinal, 
respiratory, and vague autonomic symptoms in infants. Finnegan scores determine whether or 
not pharmacological treatment for NAS will be initiated and also help to determine the dosing 
regimen of the chosen pharmacological method. It should be noted that the Finnegan scoring 
system is only validated for opiate withdrawal; therefore, it may not be an accurate scoring 
system for neonates exposed to other substances (Mohamed et al., 2006).  
Isemann, Meinzen-Derr, and Akinbi (2011) used the Finnegan abstinence scoring method 
to measure the severity of NAS. Their findings suggested that the volume of maternal breast milk 
ingested reduced incidence and severity of NAS in both preterm and term infants. Similarly, 
Mohamed, Abde-Latif, Pinner, Clews, Cooke, Lui, and Oei (2006) monitored infants for NAS 
using the Finnegan objective scoring system and found that breastfed infants exposed to multiple 
drugs in utero had worse Finnegan scores than infants exposed to only a single drug in utero, but 
had significantly better scores than formula-fed infants. 
McQueen, Murphy-Oikonen, Gerlach, and Montelpare (2011) used a modified Finnegan 
Scoring Tool that consisted of 30 items used to measure withdrawal including central nervous 
system, metabolic, vasomotor, respiratory, and gastrointestinal symptoms. In this modified 
Finnegan Scoring Tool, the maximum score that could be recorded was 44 while the minimum 
score was 0. A score of eight or greater suggested withdrawal in neonates (McQueen et al., 
2011). Initial scores were recorded at birth and every two hours after birth for the first 48 hours 
for the neonate exposed to methadone in utero. Afterwards, scores were recorded every 4 hours 
for 72 hours and then as required by hospital policy. If scores greater than 8 were recorded, 
further scores were recorded every two hours. The number of NAS scores recorded differed 
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between breastfed and formula-fed infants. The mean number of NAS scores recorded of 
predominantly breastfed infants was 25.0 while the mean number of scores recorded for formula-
fed infants was 95.6 (McQueen et al., 2011). Additionally, the predominantly breastfed infants 
had a lower severity of NAS symptoms than the formula-fed infants indicated by a lower 
magnitude Finnegan score. The overall mean NAS score of breastfed infants was 4.9 while the 
mean overall NAS score of formula-fed infants was 6.9 (McQueen et al., 2011). A limitation to 
this study is that the reliability and validity of this tool was not established; therefore, some 
instrumentation bias may have existed (McQueen et al., 2011).  
O’Connor, Collett, Alto, and O’Brien (2013) also used a modified Finnegan Scoring 
System to measure the degree of withdrawal symptoms in buprenorphine-exposed neonates. The 
results suggest that breastfeeding may reduce the severity of NAS in infants exposed to 
buprenorphine. The mean peak NAS score of breastfed infants was 8.83 while the mean peak 
NAS score of non-breastfed infants was 9.65. If three or more consecutive scores greater than or 
equal to 8 were recorded for infants, pharmacological treatment of NAS was indicated. Breastfed 
infants were less likely to score greater than or equal to 8 than non-breastfed infants. 
Additionally, symptoms of NAS were found to resolve about two hours earlier in breastfed 
infants than in formula-fed infants. A limitation to this study was the ability to control all 
variables. Some nonpharmacological interventions for NAS occur with breastfeeding, so it is not 
possible to distinguish the potential impact of breastfeeding from interventions such as 
swaddling or kangaroo care on the reduction of NAS symptoms (O’Connor et al., 2013). 
Multiple studies have found reduced need for pharmacological treatment for NAS in 
breastfed infants exposed to buprenorphine (O’Connor et al., 2013; Pritham et al., 2012). 
According to O’Connor et al. (2013), buprenorphine-exposed neonates who were breastfed were 
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less likely to require pharmacological management of NAS than buprenorphine-exposed infants 
who were not breastfed. They discovered that 23.1% of breastfed infants of mothers maintained 
on buprenorphine during pregnancy required treatment for NAS while 30.0% of non-breastfed 
infants required treatment for NAS. 
While some researchers have found decreased incidence of pharmacological treatment for 
NAS in breastfed infants exposed to buprenorphine, Welle-Strand, Skurtveit, Jansson, Bakstad, 
Bjarko, and Ravndal (2013) found no reduced need for pharmacological management of NAS in 
buprenorphine-exposed infants when breastfeeding was introduced. In their study, 64% of 
breastfed infants exposed to buprenorphine required pharmacological treatment for NAS while 
44% of buprenorphine-exposed infants who were not breastfed required treatment for NAS. The 
cohort in their study consisted of both women in methadone maintenance treatment and women 
in buprenorphine maintenance treatment which allowed for the comparison of the effects of both 
drugs on the neonate; however, the study groups, especially for buprenorphine, were small. The 
study group consisted of 78 infants exposed to methadone and 46 infants exposed to 
buprenorphine. The small study groups made it difficult to detect any significant differences 
between buprenorphine-exposed infants who were breastfed and buprenorphine-exposed infants 
who were not breastfeed (Welle-Strand et al., 2013). Future research needs to examine if 
breastfeeding reduces the need for pharmacological treatment for NAS in infants exposed to 
buprenorphine (O’Connor et al., 2013; Welle-Strand et al., 2013).  
Summary.  Researchers studying the effects of breastfeeding consistently found that 
breastfeeding may reduce the incidence and duration of pharmacological treatment of NAS, 
reduce the length of hospitalization, and reduce the severity of NAS(Dryden et al., 2009; 
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Isemann et al., 2011; McQueen et al., 2011; Mohamed et al., 2006; O'Connor et al., 2013; 
Pritham et al., 2012; Welle-Strand et al., 2013).   
Rooming-In. Non-pharmacological measures such as rooming-in are commonly used 
along with pharmacological measures to treat neonatal abstinence syndrome. Four studies in this 
systematic review tested the effects of rooming-in on neonatal abstinence syndrome (Abrahams, 
Kelly, Payne, Thiessen, Mackintosh, & Janssen, 2007; Grossman, Berkwitt, Osborn, Xu, 
Esserman, Shapiro, & Bizzaro, 2017; Holmes, Atwood, Whalen, Beliveau, Jarvis, Matulis, & 
Ralston, 2016; Newman, Davies, Dow, Holmes, Macdonald, Mcknight, & Newton, 2015). The 
researchers measured outcomes of length of hospital stay, hospital cost, severity of NAS 
symptoms, and need for pharmacological treatment.  Samples included neonates suffering from 
NAS with sample sizes ranging from 26 to 287 neonates.  Three of the four studies included had 
sample sizes under 45 neonates. Of the four studies, the designs were retrospective cohort design 
and retrospective chart review. Each study took place in single-site hospitals, ranging from rural 
to inner-city settings. The studies took place in British Columbia, United States, and Ontario. 
Limitations of these studies included small samples, potential biases in NAS scoring systems due 
to the scoring tool relying on some subjective data, inconsistencies in pharmacological treatment, 
changes in hospital policies during the course of the study, and non-randomized group 
assignment. 
 Across studies researchers consistently found that admitting neonates directly to inpatient 
rooms, by-passing neonatal intensive care units (NICU), led to shorter lengths of hospital stay, 
decreased hospital costs, reduced severity of NAS symptoms, and decreased need for 
pharmacological treatment (Abraham et al., 2007; Grossman et al., 2017; Holmes et al., 2016; 
Newman et al., 2015). For example, Grossman et al. (2017) studied 287 neonates with NAS at 
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Yale New Haven Children’s Hospital and investigated the effects of implementing 
nonpharmacological interventions, administering morphine, and transferring infants directly to 
the inpatient unit on the average length of hospital stay for infants with NAS. This was a long-
term study in which the researchers collected data from January 2008 until June 2016. In March 
2010 a quality improvement (QI) project was implemented at this hospital. The QI project had 
neonates placed in a low stimulation environment, and encouraged parents to room-in, 
continuously care for their neonates, feed their neonates on demand, and tend to neonates if 
crying. Mothers were encouraged to breastfeed infants as long as there were no 
contraindications, such as HIV.  Staff was trained to view nonpharmacological interventions as 
equal to pharmacological interventions, and to increase parent involvement before implementing 
pharmacological treatment. The use of the Finnegan Neonatal Abstinence Scoring system 
(FNASS) was discontinued and instead a functional assessment was developed that focused on 
the infant’s ability to eat, sleep, and be consoled. The scores of this functional assessment 
determined whether or not the infant needed to be given morphine. Of the 421 infants over the 
gestational age of 35 weeks that were diagnosed with NAS during the study period, only 287 
were included in the study. Those excluded were infants either not exposed to methadone or 
those with serious comorbid conditions. Of the 287 infants, 55 were in the pre-implementation 
period, 188 in the intervention period, and 44 in the post-implementation period. The pre-
implementation and post-implementation periods had to do with the QI project that was 
implemented in March 2010. Infants born before March 2010 were part of the pre-
implementation period, and infants born after May 2015 were considered part of the post-
implementation period. The average length of stay (ALOS) decreased from 22.4 days in the pre-
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implementation to 5.9 days in the post-implementation period; and the proportion of infants 
treated with morphine decreased from 98% to 14%. 
 Grossman et al. (2017)’s findings about decreased length of hospital stay are in line with 
those of Abrahams et al. (2007), who examined the effects of rooming-in on need for 
pharmacological treatment, need for admission to a neonatal intensive care nursery, and ALOS, 
all of which represented severity of NAS symptoms.  Specifically, Abrahams et al (2007) 
conducted the study at a hospital in Vancouver, British Columbia and compared outcomes of 
three subsamples of mothers who used heroin or methadone during pregnancy (Abrahams et al., 
2007). The study cohort consisting of 32 new mothers admitted to BC Women’s Hospital 
(BCWH) between October 2001 and December 2002, was compared to two historical cohorts 
that consisted of women who gave birth between January 1999 and September 2001. The study 
cohort took place after the implementation of rooming-in at BCWH. Mothers were instructed by 
nurses about how to care for infants and how to identify symptoms of NAS. The first historical 
cohort consisted of 38 women who disclosed use of heroin or methadone during pregnancy. The 
second historical cohort consisted of 36 women who also reported use of heroin or methadone. 
The women in the historical cohorts received the same care as those in the study cohort, but had 
not had rooming-in; instead, infants were admitted to a level II nursery. Outcomes of this study 
demonstrate that rooming-in was associated with a decreased need for pharmacological 
treatment, decreased need for admission to a neonatal intensive care nursery, and decreased 
ALOS. A limitation of this study was that the effects of rooming-in could not be separated from 
the effects of breastfeeding. Sixty percent of women in the study cohort breastfed, while only 
10% of women in the comparison groups breastfed.  
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Summary.  Researchers consistently found that rooming-in led to shorter length of 
hospital stay, decreased hospital costs, reduced severity of NAS symptoms, and decreased need 
for pharmacological treatment, suggesting reliability of this group of studies. 
Acupuncture. Another non-pharmacological intervention used for infants suffering from 
NAS is acupuncture. Two studies tested the effects of acupuncture on the treatment of NAS 
(Filippeli, White, Spellman, Broderick, Highfield, Sommers, & Gardiner, 2012; Raith, 
Schmolzer, Resch, Reiterer, Avian, Koestenberger, & Urlesberger, 2015). Raith et al. (2015) 
examined the effect of laser acupuncture on length of morphine treatment and average length of 
hospital stay in 28 neonates at a hospital in Austria. Laser acupuncture increases the levels of 
endomorphin, endorphins, encephalin, and serotonin and causes analgesia and sedation. The 
design of the study was a randomized, controlled, blinded, single-center study. The study was 
blinded by having both the control group and the test group spend time in the treatment room 
where the test group received acupuncture treatment and the control group simply spent time 
lying in bed. The use of laser acupuncture was found to significantly decrease the duration of 
morphine therapy in newborns with NAS. The median drug treatment for the acupuncture group 
was 28 days compared to 39 days for the control group. Neonates who received laser 
acupuncture also had shorter lengths of hospital stay. The ALOS for the acupuncture group was 
35 days compared to 50 days for the control group. While this study suggests that laser 
acupuncture is a safe way to reduce length of morphine treatment and ALOS, the small sample 
must be taken into consideration as a limitation to this study. 
 Filippeli et al. (2012) looked at the effects of non-insertive acupuncture (NIA) on the 
symptoms associated with NAS in a retrospective chart review of 54 neonates with NAS The 
neonates received a total of 92 NIA sessions, which involved an acupuncturist stimulating seven 
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acupuncture points with a teishin or finger. The researchers found that 28 neonates slept through 
the treatment or fell asleep immediately after the treatment. Of those who slept through the 
treatment, one neonate experienced deeper sleep following treatment. Effects were more 
prominent in neonates who were agitated prior to treatment. Additionally, 13 neonates exhibited 
signs of released tension during NIA treatment. Findings also revealed that better feeding 
followed NIA treatment, with eight neonates showing higher caloric intake for the days 
following treatment. The infants receiving NIA as an adjunctive treatment along with 
pharmacological interventions were found to reveal deeper sleep, better feedings, and more even 
breathing. A limitation of this study was that acupuncturists were only available one day a week 
resulting in some infants being treated early in their stay and others being treated later in their 
stay. 
Critical Appraisal 
In general, researchers have found that breastfeeding, rooming-in, and acupuncture have 
positive effects of decreasing the need for pharmacological treatment, NAS symptoms, hospital 
costs, and length of hospital stay for infants with NAS when used in conjunction with 
pharmacologic agents. In this section, quality (validity and reliability) of the studies is discussed 
with pharmacology studies discussed first, followed by studies about breastfeeding, rooming, and 
then acupuncture.   
Pharmacological methods.  There is an abundant amount of research about 
pharmacological interventions of babies with NAS. The six studies that were included in this 
systematic review were appraised on validity and reliability (Cleary et al., 2013; Dryden et al., 
2009; Ebnar et al., 2007; Jones et al., 2010; Kakko, et al., 2008; Kuschel et al., 2004). Because 
the findings across studies were consistent, it can be concluded that they are reliable. Validity 
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was questioned with the studies relating to small samples (Cleary et al., 2013; Ebnar et al., 2007; 
Kakko, et al., 2008; Kuschel et al., 2004), no group randomization (Ebnar et al., 2007; Kakko et 
al., 2008; Kuschel et al., 2004), dosages not being stated (Jones et al., 2010), attrition, e.g., 
participants not showing to follow up appointments (Dryden et al., 2009), and varying severities 
of addiction and age of the pregnant women (Kakko et al., 2008). 
Designs of these studies show many strengths and include: prospective cohort (Cleary et 
al., 2013; Kakko et al., 2008), retrospective (Dryden et al., 2009), double-blind, double-dummy 
(Jones et al., 2010) random and controlled (Jones et al., 2010). The level of evidence on these 
studies is also something to consider when discussing validity and limitations. Levels of 
evidence were: level III (Dryden et al., 2009), level V (Jones et al., 2010), level VI (Ebnar et al., 
2007; Kakko et al., 2008; Kuschel et al., 2004), and level VII (Cleary et al., 2013).  Internal 
validity was also increased when participants were all on the same medication, because it was 
easier to conclude findings of the particular medication. In three of the studies, researchers 
looked at women who were only on Methadone, which allowed researchers to compare data 
pertaining to this specific drug along with other variables that may be present (Cleary et al., 
2013; Dryden et al., 2009; Kuschel et al., 2004). 
Breastfeeding. Breastfeeding and its effects on NAS has been researched extensively in 
the literature. Researchers of seven studies in this systematic review tested the effects of 
breastfeeding on  abstinence syndrome (Dryden et al., 2009; Isemann et al., 2011; McQueen et 
al., 2011; Mohamed et al., 2006; O'Connor et al., 2013; Pritham et al., 2012; Welle-Strand et al., 
2013).  The consistent findings across studies suggest the reliability of studies.  As previously 
noted, limitations of study and threats to internal and external validity included small samples of 
buprenorphine-exposed neonates (Welle-Strand et al., 2013), affecting the statistical conclusion 
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validity of findings; however, breastfeeding in larger samples of methadone-exposed infants 
were studied in the literature. Researchers found that breastfeeding had positive outcomes 
whether using smaller samples of buprenorphine-exposed or larger samples of methadone-
exposed infants (Dryden et al., 2009; Isemann et al., 2011; Mohamed et al., 2006; Pritham et al., 
2012; Welle-Strand et al., 2013).  
Potential Finnegan instrumentation bias was also noted and contributes to threats to 
internal validity (Isemann et al., 2011). A modified Finnegan scoring tool was used by 
researchers in two studies (O’Connor et al., 2013; McQueen et al., 2011). The reliability and 
validity of the modified Finnegan scoring tool is not well-established but it has been used in 
numerous studies to guide and compare various treatments for NAS (McQueen et al., 2011). The 
Finnegan abstinence scoring method is a subjective assessment of NAS designed for term infants 
and may not be sensitive to detecting NAS in preterm infants.  However, more term neonates 
were included in the research than preterm neonates (Isemann et al., 2013). Additionally, while 
the Finnegan scoring system is only validated for opiate withdrawal, no reliable system has been 
created to assess non-opiate effects.  However, the majority of the participants in the samples 
were exposed to opiates (Mohamed et al., 2006).  
Researchers also used retrospective data collection from available medical records, which 
may have resulted in missing data (Dryden et al., 2009; Isemann et al., 2011; McQueen et al., 
2011; Mohamed et al., 2006; O’Connor et al., 2013; Pritham et al., 2012; Welle-Strand et al., 
2013).  However, retrospective data collection is an efficient way to collect data from larger 
samples and it minimizes recall bias. Retrospective data collection is valuable and is often used 
to direct future retrospective data collection in research. While the majority of the researchers 
used retrospective data collection from available medical records, researchers of one cohort 
NEONATAL ABSTINENCE SYNDROME                                                                                21  
 
study used a prospective data collection. The researchers compared background characteristics, 
pregnancy variables, and neonatal outcomes linked to feeding method across the three study 
groups (Welle-Strand et al., 2013). 
 Rooming-in. Researchers of four studies researched the effects of rooming-in on 
outcomes in neonates with NAS (Abrahams et al., 2007; Grossman et al., 2017; Holmes et al., 
2016; Newman et al., 2015), measuring outcomes of average length of hospital stay, average 
hospital cost, severity of NAS symptoms, and need for pharmacological treatment.  Sample sizes 
across studies ranged from 26 to 287 infants, with samples in three of the four studies of less 
than 45 infants. Researchers consistently found that rooming-in led to shorter length of hospital 
stay, decreased hospital costs, reduced severity of NAS symptoms, and decreased need for 
pharmacological treatment, suggesting reliability of this group of studies. Because findings of 
these studies are consistent despite having different settings and populations, these practices can 
likely be applied to other populations and have similar outcomes. Limitations of these studies 
included small samples (Abraham et al., 2007; Newman et al., 2017), potential biases in NAS 
scoring systems due to the scoring tool relying on some subjective data (Newman et al., 2015), 
inconsistencies in pharmacological treatment (Holmes et al., 2016), changes in hospital policies 
during the course of the study (Grossman et al., 2017), and non-randomized allocation of 
subjects to study groups (Abrahams et al., 2007).  
Acupuncture.  Another non-pharmacological intervention used for neonates with NAS is 
acupuncture. Researchers of two studies examined the effects of acupuncture on outcomes in 
neonates with NAS (Filippeli et al., 2012; Raith et al., 2015). One group of researchers examined 
the effect of laser acupuncture in 28 newborns to test two outcomes: length of morphine 
treatment and average length of hospital stay (Raith et al., 2015). The use of laser acupuncture 
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was found to increase endorphins and lead to analgesia, which significantly decreased duration 
of morphine therapy and length of hospital stay in newborns with NAS. While these researchers 
found that the use of laser acupuncture has favorable outcomes, the small sample must be taken 
into consideration as a limitation to this study and threat to external validity.   
In another study regarding acupuncture, researchers also looked at the effects of non-
insertive acupuncture (NIA) on the symptoms associated with NAS (Filippeli et al., 2012). In the 
study, 54 infants received a total of 92 NIA sessions, which involved an acupuncturist 
stimulating seven acupuncture points with a teishin or finger. The infants receiving NIA as an 
adjunctive treatment along with pharmacological interventions were found to have deeper sleep, 
better feedings, and more even breathing. A limitation of this study was that acupuncturists were 
only available one day a week, resulting in some infants being treated early in their stay and 
others being treated later in their stay. While the findings in this study demonstrated reliability 
and internal validity, this single study is not enough to conclude external validity.  
Synthesis 
Breastfeeding. Researchers have found that breastfeeding as a nonpharmacological 
measure reduced the incidence and length of pharmacological management of NAS, reduced the 
length of hospital stay, and reduced the incidence and severity of NAS symptoms (Dryden et al., 
2009; Isemann et al., 2011; McQueen et al., 2011; Mohamed et al., 2006; O'Connor et al., 2013; 
Pritham et al., 2012; Welle-Strand et al., 2013). Strengths of studies included large samples of 
methadone-exposed neonates with NAS and the reduction of recall bias through the use of 
retrospective data collection. Instruments used to measure the severity of NAS were consistent 
across studies. Based on the critical appraisal of these studies, breastfeeding as a 
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nonpharmacological method should be used in addition to pharmacological methods to reduce 
the incidence, length, and severity of NAS as well as reduce the length of hospital stay for NAS. 
Rooming-in. Researchers found that the use of nonpharmacological method of rooming-
in has reduced average length of stay, reduced hospital costs, reduced severity of NAS 
symptoms, and decreased the need for pharmacological treatments (Abrahams et al., 2007; 
Grossman et al., 2017; Holmes et al., 2016; Newman et al., 2015). Based on the critical appraisal 
of these studies, findings were consistent across studies, therefore suggesting reliability. 
Researchers of these studies did see a change in anticipated outcomes, therefore confirming that 
rooming-in leads to favorable outcomes.  
Acupuncture. Researchers have found that the use of different acupuncture techniques as 
an adjunctive therapy reduced length of stay, decreased need for pharmacological treatment, 
decreased signs of discomfort in neonates, and increased feeding times (Filippeli et al., 2012; 
Raith et al., 2015). The purpose of acupuncture is to achieve pain relief. These studies supported 
this theory by examining for signs of increased comfort following acupuncture therapy, and 
examining the effect acupuncture has on length of stay, and need for pharmacological treatment. 
Although these preliminary findings are promising and consistent for effects on positive 
outcomes, external validity cannot be implied from these two studies alone.  
Implications and Recommendations for Practice 
 Pharmacological methods. Based on the evidence, it is important for nurses to motivate 
and enroll new mothers in opioid maintenance programs for the health and safety of their babies 
(Ebnar et al., 2007). It is important to start them as early as they can, even before pregnancy if 
possible (Kakko et al., 2008). If a mother is noncompliant and the neonate goes into withdrawal, 
it is important for nurses to use morphine to manage symptoms (Ebnar et al., 2007). Future 
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researchers should conduct studies with larger samples, control groups, and control statistically 
for extraneous variables, since randomized group assignment is rarely used in research about this 
topic.   There should also be research about compliance to opioid maintenance programs and 
effectiveness of interventions, e.g., motivational interviewing, on outcomes to increase 
compliance rates. 
Breastfeeding. Based on quality of evidence of this systematic review, pregnant women 
who misuse drugs should be strongly encouraged and supported to breastfeed in the absence of 
any contraindications (Dryden et al., 2013; Isemann et al., 2011; McQueen et al., 2011; 
Mohamed et al., 2006; Pritham et al., 2012; Welle-Strand et al., 2013). Breastfeeding education 
should be provided to these women during the prenatal period, early in their pregnancies 
(O’Connor et al., 2013; McQueen et al., 2011; Welle-Strand et al., 2013). Information about 
breastfeeding from interdisciplinary healthcare professions should be consistent (Welle-Strand et 
al., 2013). An extended postnatal stay may also be beneficial so nurses can watch for signs of 
NAS and it would also allow healthcare professionals to continue to support breastfeeding and 
provide parenting support (Dryden et al., 2013).  Future research needs to be conducted to 
continue to examine effects of breastfeeding on outcomes in neonates with NAS, especially in 
those exposed to buprenorphine (Welle-Strand et al., 2013). Additional research should be 
conducted to explore issues such as reasons for low breastfeeding rates among drug-misusing 
women and effective interventions to support these women to breastfeed (McQueen et al., 2011). 
Rooming-in. Based on the evidence, rooming-in contributes to favorable outcomes for 
neonates with NAS and therefore should be implemented in hospital settings (Abrahams et al., 
2007; Grossman et al., 2017; Holmes et al., 2016; Newman et al., 2015). Further research would 
be beneficial to provide more evidence. Future studies should consider using randomized groups 
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and larger samples. Researchers should also ensure consistencies in pharmacological treatment 
and the use of breastfeeding in participants. Further, researchers should look into the effects 
rooming-in has on medium and long-term childhood outcomes, such as growth, development, 
and behavioral outcomes of participants (Grossman et al., 2017; Newman et al., 2015). Future 
studies could also examine quality of mother-infant bonding and other longer term outcomes, 
such as involvement of child protective services (Newman et al.,2015). 
Acupuncture.  Based on evidence, the use of laser acupuncture reduced length of 
pharmacological treatment and reduced length of hospital stay (Raith et al., 2015). Evidence has 
also shown that non-insertive acupuncture increased comfort, deeper sleep, and better feedings in 
neonates with NAS (Filippeli et al., 2012). Findings suggest that both laser acupuncture and NIA 
could be used as an adjunct to other standard treatment. Acupuncture could be especially useful 
in hospitals in areas with high prevalence of drug use, in which there is higher occurrences of 
neonates with NAS (Filipelli et al., 2012). While research has shown favorable outcomes from 
both laser acupuncture and NIA, more research should be conducted to ensure safety and 
efficacy of acupuncture in neonates. Further research should include larger randomized 
controlled studies. Future studies should consider investigating mother-delivered NIA and its 
effects on mother-neonate bonding (Filippeli et al., 2012) and also the possibility of at home 
laser acupuncture treatment programs (Raith et al., 2015).  
Conclusion  
 The management of neonates with NAS has evolved and improved greatly over the past 
twenty years. These advances have been supported by evidence about the effects of 
nonpharmacological interventions on outcomes of neonates with NAS.  Breastfeeding may 
reduce the incidence and duration of pharmacological treatment of neonates with NAS, reduce 
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the length of hospitalization, and reduce the severity of NAS (Dryden et al., 2009; Isemann et al., 
2011; McQueen et al., 2011; Mohamed, Abde-Latif et al., 2006; O'Connor et al., 2013; Pritham 
et al., 2012; Welle-Strand et al., 2013). When combined with Buprenorphine, the best choice for 
a pharmacological treatment, outcomes in this population have significantly improved. Infants 
with NAS receiving nonpharmacological interventions, such as rooming-in and acupuncture, are 
found to have better outcomes than infants receiving only pharmacological treatment (Abrahams 
et al., 2007; Filippeli et al., 2012; Grossman et al., 2017; Holmes et al., 2016; Newman et al., 
2015; Raith et al., 2015). Overall, researchers have found that breastfeeding, rooming-in, and 
acupuncture have positive effects of decreasing the need for pharmacological treatment, NAS 
symptoms, hospital costs, and length of hospital stay for infants with NAS when used in 
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